Related references
Note: Only part of the references are listed.The Evolution of a Migraine Attack - A Review of Recent Evidence
Andrew Charles
HEADACHE (2013)
The role of calcitonin gene-related peptide on the increase in transient receptor potential vanilloid-1 levels in trigeminal ganglion and trigeminal nucleus caudalis activation of rat
Duangthip Chatchaisak et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2013)
Calcitonin-gene related peptide and cerebral vasospasm
Karl-Michael Schebesch et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
Influence of varying estrogen levels on trigeminal CGRP release in healthy women
K. Ibrahimi et al.
JOURNAL OF HEADACHE AND PAIN (2013)
Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study
Faisal Mohammad Amin et al.
LANCET NEUROLOGY (2013)
Prostaglandin E2 induces immediate migraine-like attack in migraine patients without aura
Maria Antonova et al.
CEPHALALGIA (2012)
Intrathecal dihydroergotamine inhibits capsaicin-induced vasodilatation in the canine external carotid circulation via GR127935- and rauwolscine-sensitive receptors
Bruno A. Marichal-Cancino et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Signaling through the neuropeptide GPCR PAC1 induces neuritogenesis via a single linear cAMP- and ERK-dependent pathway using a novel cAMP sensor
Andrew C. Emery et al.
FASEB JOURNAL (2012)
54th Annual Scientific Meeting of the American Headache Society
HEADACHE (2012)
Effect of CGRP and sumatriptan on the BOLD response in visual cortex
Mohammad S. Asghar et al.
JOURNAL OF HEADACHE AND PAIN (2012)
Future trends in drugs for migraine prophylaxis
Piero Barbanti et al.
NEUROLOGICAL SCIENCES (2012)
The 2012 Hormone Therapy Position Statement of The North American Menopause Society
[Anonymous]
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2012)
Basic mechanisms of migraine and its acute treatment
Lars Edvinsson et al.
PHARMACOLOGY & THERAPEUTICS (2012)
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
Hans-Christoph Diener et al.
CEPHALALGIA (2011)
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
David J. Hewitt et al.
CEPHALALGIA (2011)
The 5-HT1 receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: Further involvement of 5-HT1F, but not 5-HT1A or 5-HT1D, subtypes
Abimael Gonzalez-Hernandez et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Antimigraine Efficacy of Telcagepant Based on Patient's Historical Triptan Response
Tony W. Ho et al.
HEADACHE (2011)
Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus
Oliver Summ et al.
BRAIN (2010)
Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974)
Simon R. Sinclair et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model
K. Y. Chan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache
Hans Olav Hoivik et al.
CEPHALALGIA (2010)
CGRP receptor antagonist olcegepant (BIBN4096BS) does not prevent glyceryl trinitrate-induced migraine
J. F. Tvedskov et al.
CEPHALALGIA (2010)
Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries
Lars Edvinsson et al.
CEPHALALGIA (2010)
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
Jakob Moller Hansen et al.
CEPHALALGIA (2010)
Animal models of headache: from bedside to bench and back to bedside
Anna P. Andreou et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2010)
Single- and Multiple-Dose Pharmacokinetics and Tolerability of Telcagepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, in Adults
Tae H. Han et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Pharmacological Properties of MK-3207, a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist
Christopher A. Salvatore et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Characterization of the Calcitonin Gene-Related Peptide Receptor Antagonist Telcagepant (MK-0974) in Human Isolated Coronary Arteries
K. Y. Chan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
New drugs in migraine treatment and prophylaxis: telcagepant and topiramate
Lars Edvinsson et al.
LANCET (2010)
GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus
Anna P. Andreou et al.
NEUROBIOLOGY OF DISEASE (2010)
Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers
M. S. Asghar et al.
NEUROLOGY (2010)
CGRP Receptor Antagonism and Migraine
Lars Edvinsson et al.
NEUROTHERAPEUTICS (2010)
The relevance of preclinical research models for the development of antimigraine drugs: Focus on 5-HT1B/1D and CGRP receptors
Saurabh Gupta et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Regulation of signal transduction by calcitonin gene-related peptide receptors
Christopher S. Walker et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Possible sites of action of the new calcitonin gene-related peptide receptor antagonists
Sajedeh Eftekhari et al.
Therapeutic Advances in Neurological Disorders (2010)
PACAP38 induces migraine-like attacks in patients with migraine without aura
Henrik Winther Schytz et al.
BRAIN (2009)
Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus
Marie-Luise Sixt et al.
BRAIN (2009)
Calcitonin gene-related peptide receptor inhibition reduces neuronal activity induced by prolonged increase in nitric oxide in the rat spinal trigeminal nucleus
S. Koulchitsky et al.
CEPHALALGIA (2009)
Prostaglandin E2 (PGE2) induces headache in healthy subjects
T. Wienecke et al.
CEPHALALGIA (2009)
EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force
S. Evers et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
SEVEN TOPICS IN FUNCTIONAL MAGNETIC RESONANCE IMAGING
Peter A. Bandettini
JOURNAL OF INTEGRATIVE NEUROSCIENCE (2009)
Role of Calcitonin Gene-Related Peptide in Light-Aversive Behavior: Implications for Migraine
Ana Recober et al.
JOURNAL OF NEUROSCIENCE (2009)
Calcitonin gene-related peptide, adrenomedullin and flushing
Debbie L. Hay et al.
MATURITAS (2009)
Randomized, controlled trial of telcagepant for the acute treatment of migraine
K. M. Connor et al.
NEUROLOGY (2009)
CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat
J. Zeller et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine
A. Rahmann et al.
CEPHALALGIA (2008)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis
Y. Sakai et al.
NEUROLOGY (2008)
Calcitonin gene-related peptide-mediated cardioprotection of postconditioning in isolated rat hearts
Dai Li et al.
REGULATORY PEPTIDES (2008)
Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
T. W. Ho et al.
NEUROLOGY (2008)
Pharmacological characterization of MK-0974 [N-[(3R, 6S)-6(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b] pyridin-1-yl)piperidine-1-carboxamide], a potent and orally Active calcitonin gene-related peptide receptor antagonist for the treatment of migraine
Christopher A. Salvatore et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Inhibitory effect of BIBN4096BS, CGRP8-37, a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery
L. Edvinsson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Reproducibility of the capsaicin-induced dermal blood flow response as assessed by laser Doppler perfusion imaging
B. J. Van der Schueren et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Migraine, the menopause and hormone replacement therapy: a clinical review
E. Anne MacGregor
JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE (2007)
Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion
Zhongming Zhang et al.
JOURNAL OF NEUROSCIENCE (2007)
Pharmacological characterisation of capsaicin-induced relaxations in human and porcine isolated arteries
Saurabh Gupta et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2007)
The global burden of headache: a documentation of headache prevalence and disability worldwide
L. J. Stovner et al.
CEPHALALGIA (2007)
Recent advances in understanding migraine mechanisms, molecules and therapeutics
Peter J. Goadsby
TRENDS IN MOLECULAR MEDICINE (2007)
Intravital microscopy on a closed cranial window in mice: a model to study trigeminovascular mechanisms involved in migraine
S. Gupta et al.
CEPHALALGIA (2006)
Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: A migraine target?
Kevin G. Shields et al.
NEUROBIOLOGY OF DISEASE (2006)
The role of calcitonin gene-related peptide (CGRP) in ischemic preconditioning in isolated rat hearts
WX Chai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Animal models of migraine: looking at the component parts of a complex disorder
A. Bergerot et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Effects of 5-HT1B/1D receptor agonist rizatriptan on cerebral blood flow and blood volume in normal circulation
H Okazawa et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2006)
TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice
LH Wang et al.
CIRCULATION (2005)
Topiramate inhibits trigeminovascular activation: an intravital microscopy study
S Akerman et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
CGRP release and c-fos expression within trigeminal nucleus caudalis of the rat following glyceryltrinitrate infusion
N Offenhauser et al.
CEPHALALGIA (2005)
The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers
KA Petersen et al.
CEPHALALGIA (2005)
Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?
KG Shields et al.
BRAIN (2005)
Calcium channels modulate nociceptive transmission in the trigeminal nucleus of the cat
KG Shields et al.
NEUROSCIENCE (2005)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The aura: a tertiary care study of 952 migraine patients
L Kelman
CEPHALALGIA (2004)
Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat
RJ Storer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Safety, tolerability and pharmacokinetics of BIBN4096BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers
M Iovino et al.
CEPHALALGIA (2004)
Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism
S Akerman et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Ergotamine and dihydroergotamine: History, pharmacology, and efficacy
SD Silberstein et al.
HEADACHE (2003)
Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels
S Akerman et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
The cardioprotection of calcitonin gene-related peptide-mediated preconditioning
YJ Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
CGRP may play a causative role in migraine
LH Lassen et al.
CEPHALALGIA (2002)
Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment
MJ Moreno et al.
NEUROPHARMACOLOGY (2002)
Current-induced vasodilation during water iontophoresis (5 min, 0.10 mA) is delayed from current onset and involves aspirin sensitive mechanisms
S Durand et al.
JOURNAL OF VASCULAR RESEARCH (2002)
Course of primary headaches during hormone replacement therapy
RE Nappi et al.
MATURITAS (2001)
Brainstem activation specific to migraine headache
A Bahra et al.
LANCET (2001)
Receptor systems mediating c-fos expression within trigeminal nucleus caudalis in animal models of migraine
DD Mitsikostas et al.
BRAIN RESEARCH REVIEWS (2001)
Arthritic calcitonin/alpha calcitonin gene-related peptide knockout mice have reduced nociceptive hypersensitivity
LP Zhang et al.
PAIN (2001)
Increased blood pressure in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice
PRR Gangula et al.
HYPERTENSION (2000)
Share Paper
